Loading…
Intertek Pharmaceutical Services
About
Intertek Pharmaceutical Services is the pharmaceutical business line of Intertek Group plc, offering GLP, GCP and cGMP contract laboratory expertise, supply chain audits and regulatory guidance. Listed services include method development and validation, cGMP quality control testing, ICH stability storage and testing, extractables and leachables, solid state characterisation, impurity and elemental impurity analysis, formulation development, inhalation product development and clinical trial manufacturing. Its GLP and GCP-compliant bioanalytical laboratory in Manchester, UK supports pharmacokinetic, toxicokinetic, immunogenicity and biomarker studies, and Intertek states characterisation and testing expertise for antibodies, bispecifics, oligonucleotides, cell and gene therapies, viral species and vaccines.
Deterministic scores · rules-based, not AIiHow these scores are obtained: each one is computed from this profile's listed attributes — capability checkboxes, certifications, capacity figures and coverage — by a fixed formula, recomputed on every page load. Deterministic and rules-based means the score comes from a fixed, transparent formula over listed attributes — the same inputs always produce the same score. It is not AI: there is no model, no learning, and no hidden weighting. Whether a score is relevant to you depends on your specific project: a capability that raises the number may not matter for your work, and a niche strength your project needs may barely move it. Capability scores are a directional starting point, not a verdict. A lower score does not disqualify a company or consultant, and no decision should rest on the score alone — always contact the company directly to confirm the specifics for your project.
Lab capability iCounts what the profile lists across three areas: service categories add 2.5 points each (capped at 40), analytical platforms (bioanalytical, genomics, immunogenicity, and cell-and-gene-therapy assays combined) add 2 points each (capped at 30), and therapeutic areas add 3 points each (capped at 30). Levels: 80+ Comprehensive lab | 60-79 Broad capability | 40-59 Established | below 40 Emerging. Whether this dimension matters for you depends on your specific project.
0Emerging
Accreditation iAdds fixed points for each accreditation held: CAP 20, ISO 15189 14, CLIA 12, GCLP 12, ISO 17025 10, GLP 10, GMP 8. Inspection history adds more: 4 points per listed authority (up to 14) with a no-findings outcome, 3 per authority (up to 8) with minor findings, or 4 flat when authorities are listed without an adverse (OAI or VAI) outcome. Levels: 80+ Fully accredited | 60-79 Strong | 40-59 Established | below 40 Developing. Whether this dimension matters for you depends on your specific project.
18Developing
Scientific depth iAdds fixed points for each scientific capability the profile checks: genomics sequencing 18, cell-and-gene-therapy testing 18, immunogenicity testing 16, bioanalysis 16, biomarker testing 16, companion diagnostics 8, and flow cytometry 8. Levels: 80+ Cutting-edge | 60-79 Advanced | 40-59 Developing | below 40 Foundational. Whether this dimension matters for you depends on your specific project.
66Advanced
Logistics reach iRegions supported add 7 points each, capped at 45, plus fixed points for shipping capabilities: cold chain 12, cryogenic transport 12, customs expertise 10, and 7 each for dry ice, sample collection kits, and ambient transport. Levels: 80+ Global reach | 60-79 Multi-region | 40-59 Regional | below 40 Limited. Whether this dimension matters for you depends on your specific project.
0Limited
Quality iBuilt from reported metrics: on-time delivery rate contributes up to 35 points (0.35 per percent), average turnaround earns 25 at 3 days or less, 18 at up to 7, 10 at up to 14, else 3; deviation and repeat-testing rates each start at 20 and lose 2 points per percentage point. Shows Not reported (score 0) when neither on-time delivery nor turnaround is provided. Levels: 80+ Exceptional | 60-79 Strong | 40-59 Solid | below 40 Developing. Whether this dimension matters for you depends on your specific project.
0Not reported
Trial readiness iEach supported trial phase (1 through 4) adds 9 points (max 36), therapeutic areas add 2.5 each (capped at 24), and completed studies add 1 point per 20 studies (capped at 20), plus 10 each for GCLP and GMP compliance. Levels: 80+ Trial-ready | 60-79 Strong | 40-59 Established | below 40 Emerging. Whether this dimension matters for you depends on your specific project.
10Emerging
Testing capabilities
BioanalysisBiomarker testingImmunogenicityCell & gene therapy
Live record · illustrative seed data · scores deterministic, rules-based — not AI.